Results 151 to 160 of about 17,785 (168)
Some of the next articles are maybe not open access.
PSMA Power Technology Roadmap [PSMA Corner]
IEEE Power Electronics Magazine, 2022openaire +1 more source
2019
Imaging prostate cancer and metastases either by morphologic radiological approach or nuclear medicine methods has not fulfilled the expectations of the clinicians until several years. PSMA—prostate-specific membrane antigen—which can be labeled with positron-emitting isotopes mostly 68Ga—changed this setting substantially.
Robert Pichler +4 more
openaire +1 more source
Imaging prostate cancer and metastases either by morphologic radiological approach or nuclear medicine methods has not fulfilled the expectations of the clinicians until several years. PSMA—prostate-specific membrane antigen—which can be labeled with positron-emitting isotopes mostly 68Ga—changed this setting substantially.
Robert Pichler +4 more
openaire +1 more source
PSMA PET/CT for Response Assessment of 177Lu-PSMA Therapy
Seminars in Nuclear MedicineProstate-specific membrane antigen (PSMA) PET/CT has been widely integrated into the management of prostate cancer (PCa) patients with biochemical recurrence, is increasingly used for initial staging in high-risk patients prior to surgery or to identify candidates for PSMA-targeted radioligand therapy (RLT). To date, monitoring response in PCa patients
Philipp E. Hartrampf +4 more
openaire +2 more sources